Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEDI0382 in T2DM with Renal Impairment
NCT03550378Phase 2Completed
- Sponsor
- MedImmune
- Start
- Jun 2018
- Primary completion
- Feb 2019
- Modality
- Peptides
- Countries
- 2
01
Overview
A Phase 2 trial of cotadutide in type 2 diabetes mellitus (T2DM), sponsored by MedImmune. Started Jun 2018; status: completed.
02
Drugs
cotadutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03550378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03550378.